Transient and fully reversible leukocytosis in a myelodysplastic syndrome patient upon initiation of azacitidine treatment

被引：0
|
作者：
Georg Feldmann
Peter Brossart
Marie von Lilienfeld-Toal
机构：
[1] University Hospital of Bonn,Department of Internal Medicine 3, Center of Integrated Oncology (CIO) Cologne
[2] Jena University Hospital,Bonn
来源：
Annals of Hematology | 2013年 / 92卷
关键词：
White Blood Cell Count; Lenalidomide; Myelodysplastic Syndrome; Hydroxyurea; Azacitidine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1577 / 1579
页数：2
相关论文
共 50 条
  • [1] Transient and fully reversible leukocytosis in a myelodysplastic syndrome patient upon initiation of azacitidine treatment
    Feldmann, Georg
    Brossart, Peter
    von Lilienfeld-Toal, Marie
    ANNALS OF HEMATOLOGY, 2013, 92 (11) : 1577 - 1579
  • [2] Azacitidine for the treatment of myelodysplastic syndrome
    Cataldo, Vince D.
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 875 - 884
  • [3] Treatment of Myelodysplastic syndrome with azacitidine and erythropoietin
    Limaye, Sewanti
    Lipshitz, Jay
    Dulala, Renuka
    Patel, Dilip
    BLOOD, 2007, 110 (11) : 230B - 230B
  • [4] A HEMODIALYSIS PATIENT WITH MYELODYSPLASTIC SYNDROME TREATED WITH AZACITIDINE
    Hiraga, Junji
    Nishimura, Hayato
    Kurata, Hisashi
    Kagami, Yoshitoyo
    ANNALS OF ONCOLOGY, 2014, 25
  • [5] Azacitidine for Treatment of Therapy Related Myelodysplastic Syndrome
    Komrokji, Rami S.
    Al Ali, Najla H.
    Alrawi, E.
    Padron, Eric
    Perkins, Janelle
    Field, Teresa
    Lancet, Jeffrey E.
    List, Alan F.
    BLOOD, 2011, 118 (21) : 745 - 746
  • [6] Treatment outcome of 5′-azacitidine for myelodysplastic syndrome
    Kim, Y. K.
    Kim, H. J.
    Song, J. E.
    Kim, S. E.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    LEUKEMIA RESEARCH, 2013, 37 : S110 - S110
  • [7] Eosinophilic Pneumonia Associated With Azacitidine in a Patient With Myelodysplastic Syndrome
    Nair, Girish B.
    Charles, Melissa
    Ogden, Lorna
    Spiegler, Peter
    RESPIRATORY CARE, 2012, 57 (04) : 631 - 633
  • [8] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Lin, Che-Hung
    Yeh, Su-Peng
    Lin, Tze-Yi
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1925 - 1926
  • [9] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Che-Hung Lin
    Su-Peng Yeh
    Tze-Yi Lin
    Annals of Hematology, 2015, 94 : 1925 - 1926
  • [10] Treatment of myelodysplastic syndrome: Questions raised by the azacitidine experience
    Kantarjian, HM
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2415 - 2416
12345